Viewing RCC with a DNA methylation lens ENHANCES understanding of ICI resistance.
Mi ZhouWilliam Y KimPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Clear cell renal cell carcinoma tumors with an enhancer demethylator phenotype (TED) harbor a worse prognosis and derive less clinical benefit from immunotherapy. The TED phenotype may help predict immunotherapy resistance.